US Patent Issued to Meso Scale Technologies on June 17 for "Methods for diagnosing an inflammatory bowel disease based on soluble tumor necrosis factor II (sTNFRII) levels in a patient sample and treating thereafter" (Maryland, California, New Jersey Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,332,253, issued on June 17, was assigned to Meso Scale Technologies LLC (Rockville, Md.).

"Methods for diagnosing an inflammatory bowel disease based on soluble tumor necrosis factor II (sTNFRII) levels in a patient sample and treating thereafter" was invented by Jeff D. Debad (Gaithersburg, Md.), Eli N. Glezer (Del Mar, Calif.) and Sudeep M. Kumar (Basking Ridge, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods for conducting diagnostic tests for the detection of the inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. Also described are methods for monitoring a patient by administering tests of the pres...